sialorrhea/scopolamine

הקישור נשמר בלוח

בחר סוג מיון

עמוד 1 מ 51 תוצאות

Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Background: Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this

Transdermal scopolamine in drooling.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

The effect of oral anticholinergic drugs has been limited in the treatment of drooling. Transdermal scopolamine (1.5 mg/2.5 cm2) offers advantages. One single application is considered to render a stable serum concentration for 3 days. A distinct reduction of basal salivation was demonstrated in an

Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0- 97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study

The use of transdermal scopolamine to control drooling. A case report.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Drooling is a serious social handicap experienced by some neurologically impaired patients. No one method has been identified to control drooling for all patients, however, anticholinergic drugs recently have been utilized. In the case study described, transdermal scopolamine patches were found to

Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND This study investigated the efficacy of scopolamine (an anticholinergic agent) ointment against clozapine-induced hypersalivation. METHODS The patients enrolled in this study consisted of 10 clozapine-treated schizophrenia patients and 10 healthy adult men. A prospective, randomized,

Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND Sialorrhea is a distressing symptom accompanying oral cancer and many heterogeneous cancer-related conditions (chemotherapy-induced nausea, bowel subocclusion, pharmacologic side effects), but its incidence is low in cancer patients. Conversely, it is frequent in patients with

Management of drooling in disabled patients with scopolamine patches.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

OBJECTIVE To evaluate the efficacy of scopolamine administered transdermally for the treatment of drooling in severely disabled patients. METHODS A prospective, randomized, double-blind, crossover, placebo-controlled clinical trial was designed. The study group consisted of 30 handicapped patients

Transdermal scopolamine for reduction of drooling in developmentally delayed children.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Ten developmentally delayed children with excessive drooling were randomized in a double-blind, placebo-controlled study to assess the efficacy and safety of transdermal scopolamine. Over half of the patients had a statistically significant reduction in drooling, and one-third had cessation of

Treatment of drooling with scopolamine in pediatric ICU: A case series report.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Drooling is a condition that affects patients with difficulties in swallowing, being common in patients with mental, neurological or dysphagic deficiency. This condition is difficult to diagnose, as it is often confused with sialorrhea, and in many cases we have a hyposalivation scenario. Its

Control of drooling with transdermal scopolamine in a child with cerebral palsy.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Transdermal scopolamine patches (1.5 mg) were used to control drooling in a two-year-old boy with severe spastic quadriparetic cerebral palsy and developmental delay. He responded well to the continuous scopolamine therapy, with a decrease in drooling, and a secondary decrease in respiratory

Control of drooling using transdermal scopolamine skin patches. A case report.

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Transdermal scopolamine has been shown to be very useful in the management of drooling, particularly in patients with neurological or neuropsychiatric disturbances or severe developmental disorders. In this paper, we present the case of a 24-year-old patient with a diagnosis of cerebral palsy and a